Sarepta Therapeutics Inc (SRPT)
Payables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 513,751 | 454,710 | 287,854 | 318,537 | 285,661 |
| Payables | US$ in thousands | 164,918 | 95,875 | 76,741 | 111,090 | 68,094 |
| Payables turnover | 3.12 | 4.74 | 3.75 | 2.87 | 4.20 |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $513,751K ÷ $164,918K
= 3.12
Sarepta Therapeutics Inc's payables turnover has fluctuated over the past five years, ranging from a low of 2.87 in 2020 to a high of 4.74 in 2022. The payables turnover ratio indicates how efficiently the company is managing its accounts payable. A higher turnover ratio suggests that the company is paying its suppliers more quickly, potentially taking advantage of discounts and strengthening vendor relationships.
In 2023, the payables turnover decreased to 3.12, showing a slowdown in how quickly the company is paying its bills compared to the previous year. This could be due to various factors, such as changes in supplier terms, increased purchasing activity, or changes in the company's payment policies.
Overall, Sarepta Therapeutics Inc's payables turnover ratio has shown variability but generally indicates a relatively efficient management of accounts payable. It is essential for the company to monitor this ratio closely to ensure optimal cash flow management and maintain positive relationships with suppliers.
Peer comparison
Dec 31, 2023